Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.0K
Cancer Vaccines01:30

Cancer Vaccines

581
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
581
Cancer Survival Analysis01:21

Cancer Survival Analysis

481
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Elevated prostate specific antigen due to indwelling urethral catheterisation: myth or fact? A systematic review and meta-analysis.

World journal of urology·2026
Same author

Artificial intelligence in urology: A review of United States Food and Drug Administration-cleared devices.

BJU international·2026
Same author

Multicentre validation of the PRECISE scoring system for prostate MRI during active surveillance.

European radiology·2026
Same author

PRECISE Version 2: Essential Tips for Prostate Cancer Monitoring Using MRI.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
Same author

Impact of comorbidity on patient reported outcome measures for men with localised prostate cancer.

BMC urology·2026
Same author

Reply to the Letter to the Editor: Variation in prostate cancer growth rates in an MRI-based active surveillance cohort.

European radiology·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Oct 25, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.4K

前立腺がん

Shahneen Sandhu1, Caroline M Moore2, Edmund Chiong3

  • 1Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.

Lancet (London, England)
|August 9, 2021
PubMed
まとめ
この要約は機械生成です。

前立腺がんの治療における進歩には,DNA修復経路を標的としたパーソナライズされた治療法と,転移性疾患の新型アンドロゲン阻害剤による生存率の改善が含まれています. 放射性同位体や免疫療法などの 新規治療法に焦点を当てています

さらに関連する動画

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.0K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.6K

関連する実験動画

Last Updated: Oct 25, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.4K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.0K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.6K

科学分野:

  • 腫瘍学
  • 尿生殖器がんの研究

背景:

  • 前立腺がんの治療は急速に進化しています
  • ゲノムと生物学の理解は進歩しました
  • 繊細なイメージング方法により 診断とステージングが改善されました

研究 の 目的:

  • 前立腺がんの治療における 最近の進歩を振り返るため
  • パーソナライズされた治療法と新しい治療戦略の影響を強調する.
  • 前立腺がんの研究の 将来の方向性について話し合います

主な方法:

  • 現在の文献と臨床実務のレビュー
  • ゲノムと分子特性データの分析
  • 新しい治療方法の評価

主要な成果:

  • パーソナライズされた治療法は DNA修復経路を標的にします
  • 転移を狙った治療は,オリゴメタスタシス疾患において有望である.
  • 新種のアンドロゲン経路阻害剤は,転移性前立腺がんの生存率を大幅に改善します.

結論:

  • 分子特徴は局所的および進行した疾患の臨床管理に影響を与えます.
  • 標的型放射性同位体と免疫療法は 将来の治療法として有望です
  • 前立腺がん患者の治療結果を改善するために 継続的な研究が不可欠です